Nachbagauer, Raffael
Moderna Therapeutics,
United States
2025 Rank: 218292
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 945 out of 75944 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 218292 | 217353 |
| Total Cites | 590 | 704 |
| H-index | 13 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 117 | 133 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 168 | 200 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 422 | 468 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.50 |
| Self-Citation Percentage |
16.19%
|
|
Nachbagauer, Raffael
Icahn School of Medicine at Mount Sinai,
United States
2024 Rank: 211025
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 1067 out of 71672 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 211025 | 181909 |
| Total Cites | 544 | 679 |
| H-index | 13 | 15 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 111 | 141 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 160 | 201 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 390 | 442 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.54 |
| Self-Citation Percentage |
19.88%
|
|
Nachbagauer, Raffael
Moderna Therapeutics,
United States
2023 Rank: 228132
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 1365 out of 68279 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 228132 | 188115 |
| Total Cites | 503 | 650 |
| H-index | 11 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 127 | 162 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 169 | 224 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 374 | 417 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.56 |
| Self-Citation Percentage |
22.62%
|
|
Nachbagauer, Raffael
Icahn School of Medicine at Mount Sinai,
United States
2022 Rank: 146939
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 1010 out of 65731 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 146939 | 126336 |
| Total Cites | 567 | 730 |
| H-index | 13 | 15 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 149 | 189 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 180 | 242 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 379 | 439 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.66 |
| Self-Citation Percentage |
22.33%
|
|
Nachbagauer, Raffael
Icahn School of Medicine at Mount Sinai,
United States
2021 Rank: 205545
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Microbiology
Rank in SubField 1: 1352 out of 64670 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 205545 | 171377 |
| Total Cites | 675 | 893 |
| H-index | 15 | 18 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 170 | 224 |
| Number of Single+First+Last Authored Papers | 15 | 15 |
| Total Cites to Single+First+Last Authored Papers | 184 | 259 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 472 | 543 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.64 |
| Self-Citation Percentage |
24.41%
|
|
Nachbagauer, Raffael
Icahn School of Medicine at Mount Sinai,
United States
2020 Rank: 236605
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Microbiology
Rank in SubField 1: 1425 out of 58416 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 236605 | 172656 |
| Total Cites | 376 | 539 |
| H-index | 11 | 14 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 124 | 197 |
| Number of Single+First+Last Authored Papers | 12 | 12 |
| Total Cites to Single+First+Last Authored Papers | 140 | 223 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 259 | 305 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.77 |
| Self-Citation Percentage |
30.24%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.